Literature DB >> 3973860

Association of actinomyces and intrauterine contraceptive devices.

M Yoonessi, K Crickard, I S Cellino, S K Satchidanand, W Fett.   

Abstract

We analyzed the clinicopathologic aspects of 19 cases of actinomycosis associated with intrauterine devices (IUDs) seen and treated at hospitals affiliated with the State University of New York at Buffalo between 1972 and 1982. Clinical manifestations included the following: (1) asymptomatic IUD-associated Actinomyces colonization, (2) endocervicitis, (3) endometritis, (4) endometritis with salpingitis and/or tuboovarian abscesses and (5) abdominopelvic abscesses. No consistent relationship was found between the total peripheral lymphocyte count and/or degree of histologic lymphocytic reaction and the clinical picture. Abnormal uterine bleeding and/or discharge, pain, fever and abdominopelvic masses were among the symptoms and signs encountered. Patients with endocervicitis and/or endometritis responded to removal of the IUD, dilatation and curettage and antibiotic therapy for two to four weeks. Those who developed abscesses were treated successfully with surgical drainage and added antibiotic treatment.

Entities:  

Keywords:  Adnexitis; Bacterial And Fungal Diseases; Contraception; Contraceptive Methods; Diseases; Family Planning; Infections; Iud; Pelvic Infections; Pelvic Inflammatory Disease; Reproductive Tract Infections; Signs And Symptoms; Treatment

Mesh:

Year:  1985        PMID: 3973860

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  2 in total

1.  Abdominopelvic actinomycosis associated with intrauterine devices. Two case reports.

Authors:  J Mäenpää; E Taina; M Grönroos; K O Söderström; T Ristimäki; L Närhinen
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

2.  Actinomycosis presenting as an abdominal mass in a child.

Authors:  Rahsan Ozcan; Emil Mammadov; Emrah Aydin; Ibrahim Adaletli; Tugçe Esen; Sergülen Dervisoglu; Sinan Celayir
Journal:  APSP J Case Rep       Date:  2011-03-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.